A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region
出版年份 2020 全文链接
标题
A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region
作者
关键词
-
出版物
mBio
Volume 11, Issue 2, Pages -
出版商
American Society for Microbiology
发表日期
2020-03-24
DOI
10.1128/mbio.00186-20
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene
- (2020) Yingyun Cai et al. mBio
- Nigeria's unending war with Lassa fever
- (2019) Paul Adepoju LANCET
- Ribavirin for the Treatment of Lassa Fever: A Systematic Review and Meta-Analysis
- (2019) Kirsten Alexandra Eberhardt et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- ICTV Virus Taxonomy Profile: Arenaviridae
- (2019) Sheli R. Radoshitzky et al. JOURNAL OF GENERAL VIROLOGY
- A review of Lassa fever vaccine candidates
- (2019) Kolawole Salami et al. Current Opinion in Virology
- A Single Dose of Modified Vaccinia Ankara Expressing Lassa Virus-like Particles Protects Mice from Lethal Intra-cerebral Virus Challenge
- (2019) Maria S. Salvato et al. Pathogens
- Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot
- (2019) Mathieu Mateo et al. Science Translational Medicine
- Mortality Among Confirmed Lassa Fever Cases During the 2015–2016 Outbreak in Nigeria
- (2018) Maryam Ibrahim Buba et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins
- (2018) Xavier Carnec et al. JOURNAL OF VIROLOGY
- Lassa fever and global health security
- (2018) The Lancet Infectious Diseases LANCET INFECTIOUS DISEASES
- Nigeria hit by unprecedented Lassa fever outbreak
- (2018) Leslie Roberts SCIENCE
- Persistence of Lassa Virus Associated With Severe Systemic Arteritis in Convalescing Guinea Pigs (Cavia porcellus)
- (2018) David X Liu et al. JOURNAL OF INFECTIOUS DISEASES
- Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018
- (2018) Katherine J. Siddle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays
- (2018) Yíngyún Caì et al. Viruses-Basel
- Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
- (2018) Tiago Abreu-Mota et al. Nature Communications
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever
- (2017) Chad E Mire et al. NATURE MEDICINE
- Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein
- (2017) Benson Y.H. Cheng et al. VIROLOGY
- An attenuated Machupo virus with a disrupted L-segment intergenic region protects guinea pigs against lethal Guanarito virus infection
- (2017) Joseph W. Golden et al. Scientific Reports
- DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs
- (2017) Kathleen A. Cashman et al. Human Vaccines & Immunotherapeutics
- Understanding the cryptic nature of Lassa fever in West Africa
- (2017) Rory Gibb et al. Pathogens and Global Health
- Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies
- (2016) Robert W. Cross et al. ANTIVIRAL RESEARCH
- The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses
- (2016) Masaharu Iwasaki et al. JOURNAL OF VIROLOGY
- Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
- (2016) James E. Robinson et al. Nature Communications
- Development of Live-Attenuated Arenavirus Vaccines Based on Codon Deoptimization
- (2015) Benson Yee Hin Cheng et al. JOURNAL OF VIROLOGY
- General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines
- (2015) Masaharu Iwasaki et al. JOURNAL OF VIROLOGY
- Molecular Mechanism for LAMP1 Recognition by Lassa Virus
- (2015) Hadas Cohen-Dvashi et al. JOURNAL OF VIROLOGY
- The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
- (2015) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- International External Quality Assessment Study for Molecular Detection of Lassa Virus
- (2015) Sergejs Nikisins et al. PLoS Neglected Tropical Diseases
- A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
- (2015) David Safronetz et al. PLoS Neglected Tropical Diseases
- The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
- (2015) David Safronetz et al. Scientific Reports
- Lassa virus entry requires a trigger-induced receptor switch
- (2014) L. T. Jae et al. SCIENCE
- Mice Lacking Functional STAT1 Are Highly Susceptible to Lethal Infection with Lassa Virus
- (2013) N. E. Yun et al. JOURNAL OF VIROLOGY
- An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity
- (2013) Juan C Zapata et al. Virology Journal
- Vaccines for viral hemorrhagic fevers—progress and shortcomings
- (2013) Darryl Falzarano et al. Current Opinion in Virology
- Arenavirus Nucleoproteins Prevent Activation of Nuclear Factor Kappa B
- (2012) W. W. S. I. Rodrigo et al. JOURNAL OF VIROLOGY
- Reverse Genetics Recovery of Lujo Virus and Role of Virus RNA Secondary Structures in Efficient Virus Growth
- (2012) E. Bergeron et al. JOURNAL OF VIROLOGY
- Immune Responses and Lassa Virus Infection
- (2012) Marion Russier et al. Viruses-Basel
- The C-Terminal Region of Lymphocytic Choriomeningitis Virus Nucleoprotein Contains Distinct and Segregable Functional Domains Involved in NP-Z Interaction and Counteraction of the Type I Interferon Response
- (2011) E. Ortiz-Riano et al. JOURNAL OF VIROLOGY
- Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression
- (2011) K. M. Hastie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa Fever
- (2010) Daniel G. Bausch et al. CLINICAL INFECTIOUS DISEASES
- Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs
- (2010) Xiaohong Jiang et al. VACCINE
- Early and Strong Immune Responses Are Associated with Control of Viral Replication and Recovery in Lassa Virus-Infected Cynomolgus Monkeys
- (2009) S. Baize et al. JOURNAL OF VIROLOGY
- Risk Maps of Lassa Fever in West Africa
- (2009) Elisabeth Fichet-Calvet et al. PLoS Neglected Tropical Diseases
- Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates
- (2008) Igor S. Lukashevich et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started